Postpartum Psychiatric Disorders

Prevention of Postpartum Depression

Postpartum depression (PPD) is a relatively common problem, affecting between 10% and 15% of women after delivery. Although it is difficult to reliably predict which women in the general population will experience postpartum mood disturbance, it is possible to identify certain subgroups of women who are more vulnerable to postpartum affective illness. Women who have had one episode of postpartum depression have about a 50% chance of experiencing another episode of PPD after a subsequent pregnancy. The extent to which a history of depression (prior to pregnancy) influences risk is less clear, but some studies indicate that between 30% and 50% will suffer from recurrent depression during the postpartum period. Several investigators have recently explored the potential efficacy of prophylactic interventions in these populations of women at risk.

By |2015-08-07T22:57:38-04:00July 20th, 2004|Postpartum Depression, Postpartum Psychiatric Disorders, Prevention|Comments Off on Prevention of Postpartum Depression

Breastfeeding Boosts Intelligence

Over the years, various studies have demonstrated the many advantages of breastfeeding, findings that have led the American Academy of Pediatrics to recommend that all mothers breastfeed their children for the first year of the child's life. Several studies have also examined the relationship between breastfeeding and intellectual development in younger children and have demonstrated better cognitive functioning in children who were breastfed. The extent to which breastfeeding during infancy has an effect on later intellectual development has been more difficult to assess.

By |2015-07-20T11:05:48-04:00July 18th, 2002|Breastfeeding & Medications, Outcomes, Postpartum Psychiatric Disorders|Comments Off on Breastfeeding Boosts Intelligence

Venlafaxine for Postpartum Depression

Postpartum depression (PPD) is relatively common, occurring in about 10 to 15% of women after delivery. Several reports have documented the efficacy of selective serotonin reuptake inhibitors (SSRIs) sertraline, fluoxetine, and fluvoxamine for the treatment of this disorder. In a recent report, Cohen and colleagues have demonstrated the efficacy of venlafaxine for the treatment of PPD.

By |2016-03-28T13:24:00-04:00February 20th, 2002|Medication, Postpartum Depression, Postpartum Psychiatric Disorders, Treatment|Comments Off on Venlafaxine for Postpartum Depression
Go to Top